CLINICAL_TRIALS
trial_result
· 2025-08-26
Clinical Trial Update: Stop Retinal Ganglion Cell Dysfunction Study [Phase 3]
Summary
Phase 3 trial evaluating a therapy for retinal ganglion cell dysfunction in glaucoma has been terminated. Results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Miami | Conditions: Glaucoma | Phase 3 | Status: TERMINATED | Results posted: 2025-08-26